Stocks

Editas Medicine EDIT

Health care sectorNasdaq

What to see in Editas Medicine now

Is Wall Street adding or cutting?+7

215 13F filers hold it · +7 against the quarter before · shares held +132.1%

Holdings of 06/30
Who bought more than 5%?5.8%

ADAR1 Capital Management holds 5.8%

Filed 08/15
Do Korean lawmakers hold it?1

1 members of the National Assembly hold it

Published 24/03/28

Company

Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Headquarters
Cambridge, Massachusetts
Fiscal year end
12/31
Next earnings
11/03, estimated
  • 215 13F filers hold it · +7 against the quarter before · shares held +132.1%Holdings of 06/30
  • ADAR1 Capital Management holds 5.8%Filed 08/15

Funds

13F filers: 215 · +7 since the quarter before · 06/30 holdings

Famous funds that held Editas Medicine in their latest 13F report.

FundValueSince the quarter before
Mirae Asset Global ETFS HoldingsEditas Medicine EDIT · 06/30 holdings$490.6KNo quarter before
Mirae Asset Global InvestmentsEditas Medicine EDIT · 06/30 holdings$22.2KAdded +34.8%
All tracked funds

5% stakes

Holder
ADAR1 Capital Management08/145.8%8,889,000 shFirst report
BlackRock07/294.97%8,355,588 sh−2.9pp
Ra Capital Management06/035.8%8,889,000 shFirst report
TCG Crossover GP III06/039.9%15,798,999 shFirst report
Commodore Capital06/029.9%16,045,802 shFirst report
All 5% stake reports on Editas Medicine

26-week trading